Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Rett Syndrome Therapeutics Review, H2 2018 - Pipeline Analysis of 16 Companies & Drug Profiles - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Oct 18

The "Rett Syndrome - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Rett Syndrome - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Rett Syndrome (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Rett Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Rett Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 4, 9 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.

Rett Syndrome (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Rett Syndrome - Overview
  3. Rett Syndrome - Therapeutics Development
  4. Rett Syndrome - Therapeutics Assessment
  5. Rett Syndrome - Companies Involved in Therapeutics Development
  6. Rett Syndrome - Drug Profiles
  7. Rett Syndrome - Dormant Projects
  8. Rett Syndrome - Product Development Milestones

Companies Mentioned

  • AMO Pharma Ltd
  • Amorsa Therapeutics Inc
  • Anavex Life Sciences Corp
  • ArmaGen Inc
  • AveXis Inc
  • Biohaven Pharmaceutical Holding Company Ltd
  • Eloxx Pharmaceuticals Inc
  • GW Pharmaceuticals Plc
  • Mitochon Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corp
  • Neuren Pharmaceuticals Ltd
  • Neurolixis Inc
  • Newron Pharmaceuticals SpA
  • OPKO Health Inc
  • Relmada Therapeutics Inc
  • Ultragenyx Pharmaceutical Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ctv2j8/rett_syndrome?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005617/en/

Business Wire
www.businesswire.com

Last updated on: 19/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.